ASLN - ASLAN Pharmaceuticals Limited

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5205.93M
Enterprise value 31.06B
Trailing P/E N/A
Forward P/E 1-8.99
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)40.15
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6-27.34

Financial highlights

Currency in TWD.

Fiscal year

Fiscal year ends 31 Dec 2017
Most-recent quarter (mrq)31 Mar 2018

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-50.71%
Return on equity (ttm)-134.49%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -38.85M
Net income avi to common (ttm)-39.83M
Diluted EPS (ttm)-0.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)27.21M
Total cash per share (mrq)0.21
Total debt (mrq)9.52M
Total debt/equity (mrq)37.05
Current ratio (mrq)1.92
Book value per share (mrq)0.20

Cash flow statement

Operating cash flow (ttm)-37.76M
Levered free cash flow (ttm)-24.59M

Trading information

Stock price history

Beta N/A
52-week change 3∞%
S&P500 52-week change 313.38%
52-week high 310.44
52-week low 35.08
50-day moving average 38.55
200-day moving average 37.78

Share statistics

Avg vol (3-month) 3101.47k
Avg vol (10-day) 311.03k
Shares outstanding 5130.13M
Float 92.78M
% held by insiders 10.00%
% held by institutions 10.58%
Shares Short (15 Jun 2018) 415.05k
Short Ratio (15 Jun 2018) 40.03
Short % of Float (15 Jun 2018) 4N/A
Short % of Shares Outstanding (15 Jun 2018) 40.01%
Shares Short (prior month 15 May 2018) 44.42k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 2N/A
Last split date 3N/A